Future leaders convene at the ACR/Arthritis Foundation Rheumatology Research Workshop to discuss cutting-edge research and career development.
Search results for: methotrexate
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Drug Updates
Information on new approvals and medication safety.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Coding Corner: Incident-To
A 65-year-old female Medicare patient with rheumatoid arthritis sees a nonphysician provider for a followup visit.
Systemic Juvenile Idiopathic Arthritis
Changing treatment paradigms in the biologic era
Coding Corner: May’s Coding Challenge
A 54-year-old female with rheumatoid arthritis is seen by the rheumatologist for a follow-up visit.
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances
Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk
Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 101
- Next Page »